---
title: 'Identifying differential predictors for treatment response to amisulpride
  and olanzapine combination treatment versus each monotherapy in acutely ill patients
  with schizophrenia: Results of the COMBINE-study'
date: '2024-07-10'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38986385/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240711181556&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: Early TR, drug-related subjective well-being, and early
  side effect propensity evolved as predictors for later TR whether to monotherapy
  or combination strategy. Accordingly, due to a lack of differential predictors,
  early and close monitoring of targeted and unwanted effects is indicated to guide
  respective treatment ...'
disable_comments: true
---
CONCLUSION: Early TR, drug-related subjective well-being, and early side effect propensity evolved as predictors for later TR whether to monotherapy or combination strategy. Accordingly, due to a lack of differential predictors, early and close monitoring of targeted and unwanted effects is indicated to guide respective treatment ...